   
    

\

Tam/0am? '3'

 

Sur ical Pathology Report

CLINICAL HISTOR
Not Given

OPERATIVE DIAGNOSES
Not Given

Operation/Specimen: A: Brain,tumor, biopsy
B: Brain,tumor, biopsy

PATHOLOGICAL DIAGNOSIS:
A and B. Brain biopsy: Glioblastoma multiforme, proliferation index { MIB—l

) : 40%

COMMENT
This is a high grade glioma with increased mitotic figure, prominent vascular

hyperplasia and areas of necrosis,.

PROCEDURES/ADDENDA
MGMT Promoter
Date Ordered:

ation

       

Interpretation

NEGATIVE - No evidence of methylated MGMT promoter is detected.

Results—Comments
Received were paraffin curls labeled

TEST DESCRIPTION: Bisulfite treatment of DNA followad by PCR amplification of
both methylated and unmethylated MGMT promoter sequences, with products
detected by gel electrophoresis.

FDA COMMENT: The above data are not to be construed as the results from a

stand—alone diagnostic test. This test was dev d its performance
characteristics de ined by the laboratory as
required by CLIA ‘ egulations. It has no d or approved for

1'
specific uses by the U.S. Food and Drug Administration (FDA). The FDA has
P

    

 

determined that such clearance or approval is not necessary. These results are
provided for informational purposes only, and should be interpreted only in
the context of established procedures and/or diagnostic criteria.

 

 

INTRA-OPERATIVE CONSULTATION
A. Brain, biopsy: Glioma, 1 block,-

 

GROSS DESCRIPTION
A. Multiple tissue fragmentsﬁ 0.3 to 0.6 cm, All in Al, A2

B. One 0.5 cm tissue fragment, all in El

 

ICDe9(s):
191.2 191.2

    

Histo Data

Part A: ‘ mor biopsy

Stain/cut Block red Comment
H/E x 1 1

H/E X 1 2

MGMT x l 2

MIBl-DA x 1 2

 

Part B: Brain tumor, biopsy
Taken: Received:

Stain/cut -Block rdered Comment
H/E x l 1

*** End of Report ***

 

“a...“

